Rouges, C.
Publications
P275
Microorganisms 2023, 11, 2837.
Is the C-terminal domain an effective and selective target for the design of Hsp90 inhibitors against Candida yeast?
P215
Sci. Rep. 2020, 10, 6211.
In vitro immune responses of human PBMCs against Candida albicans reveals fungal and leucocyte phenotypes associated with fungal persistence.
doi: 10.1038/s41598-020-63344-6
Thèse
T46.
L’interaction Hsp90/co-chaperonnes : nouvelle cible pour le traitement des candidoses invasives.
Direction : P. Le Pape et P. Marchand. Date de soutenance : 14 juin 2023.